These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15374583)

  • 1. Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores.
    Lenert LA; Sturley AP; Rapaport MH; Chavez S; Mohr PE; Rupnow M
    Schizophr Res; 2004 Nov; 71(1):155-65. PubMed ID: 15374583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the validity of utility elicitations performed by computerized interview.
    Lenert LA; Morss S; Goldstein MK; Bergen MR; Faustman WO; Garber AM
    Med Care; 1997 Sep; 35(9):915-20. PubMed ID: 9298080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of preferences for health outcomes in schizophrenia among stakeholder groups.
    Lee TT; Ziegler JK; Sommi R; Sugar C; Mahmoud R; Lenert LA
    J Psychiatr Res; 2000; 34(3):201-10. PubMed ID: 10867115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status.
    Ongür D; Goff DC
    Schizophr Res; 2005 Jun; 75(2-3):349-62. PubMed ID: 15885526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in health values among patients, family members, and providers for outcomes in schizophrenia.
    Lenert LA; Ziegler J; Lee T; Sommi R; Mahmoud R
    Med Care; 2000 Oct; 38(10):1011-21. PubMed ID: 11021674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-based utilities for bipolar disorder-related health states.
    Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
    J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the internet to study the utility values of the public.
    Lenert LA; Sturley AE
    Proc AMIA Symp; 2002; ():440-4. PubMed ID: 12463862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients.
    Rashidi AA; Anis AH; Marra CA
    Health Qual Life Outcomes; 2006 Apr; 4():25. PubMed ID: 16626489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
    Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
    J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences and utilities for the symptoms of moderate to severe allergic asthma.
    Lloyd A; Doyle S; Dewilde S; Turk F
    Eur J Health Econ; 2008 Aug; 9(3):275-84. PubMed ID: 18038166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
    Stauffer VL; Song G; Kinon BJ; Ascher-Svanum H; Chen L; Feldman PD; Conley RR
    Schizophr Res; 2012 Feb; 134(2-3):195-201. PubMed ID: 22019076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heterogeneity of schizophrenia in disease states.
    Mohr PE; Cheng CM; Claxton K; Conley RR; Feldman JJ; Hargreaves WA; Lehman AF; Lenert LA; Mahmoud R; Marder SR; Neumann PJ
    Schizophr Res; 2004 Nov; 71(1):83-95. PubMed ID: 15374576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing health utilities in schizophrenia. A feasibility study.
    Voruganti LN; Awad AG; Oyewumi LK; Cortese L; Zirul S; Dhawan R
    Pharmacoeconomics; 2000 Mar; 17(3):273-86. PubMed ID: 10947302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).
    Brunner HI; Maker D; Grundland B; Young NL; Blanchette V; Stain AM; Feldman BM
    Med Decis Making; 2003; 23(4):314-22. PubMed ID: 12926581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilities derived from visual analog scale scores in patients with HIV/AIDS.
    Mrus JM; Yi MS; Freedberg KA; Wu AW; Zackin R; Gorski H; Tsevat J
    Med Decis Making; 2003; 23(5):414-21. PubMed ID: 14570299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.